cycloheximide has been researched along with norharman in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Hayase, N; Maruyama, W; Matsubara, K; Mizukami, H; Naoi, M; Ogawa, K; Saito, O; Shimizu, K; Shiono, H; Uezono, T | 1 |
2 other study(ies) available for cycloheximide and norharman
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Norharman, an indoleamine-derived beta-carboline, but not Trp-P-2, a gamma-carboline, induces apoptotic cell death in human neuroblastoma SH-SY5Y cells.
Topics: Apoptosis; Carbolines; Central Nervous System; Comet Assay; Cycloheximide; DNA; DNA Fragmentation; Harmine; Humans; Mutagens; Neurons; Neurotoxins; Protein Synthesis Inhibitors; Tumor Cells, Cultured | 2001 |